Clopidogrel Proton-Pump Inhibitors Study

Summary

Clopidogrel Proton-Pump Inhibitors Study is a clinical trial^[1].

Key Facts

• Clopidogrel Proton-Pump Inhibitors Study is in the country of Israel^[2].
• Clopidogrel Proton-Pump Inhibitors Study's instance of is recorded as clinical trial^[3].
• Clopidogrel Proton-Pump Inhibitors Study's start time is recorded as +2012-12-31T00:00:00Z^[4].
• Clopidogrel Proton-Pump Inhibitors Study's end time is recorded as +2012-12-31T00:00:00Z^[5].
• Clopidogrel Proton-Pump Inhibitors Study's sponsor is recorded as Sheba Medical Center^[6].
• Clopidogrel Proton-Pump Inhibitors Study's main subject is recorded as clopidogrel^[7].
• Clopidogrel Proton-Pump Inhibitors Study's main subject is recorded as coronary artery disease^[8].
• Clopidogrel Proton-Pump Inhibitors Study's number of participants is recorded as {'unit': '1', 'amount': '+0'}^[9].
• Clopidogrel Proton-Pump Inhibitors Study's title is recorded as Clopidogrel Proton-Pump Inhibitors Study^[10].
• Clopidogrel Proton-Pump Inhibitors Study's minimum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+18'}^[11].
• Clopidogrel Proton-Pump Inhibitors Study's ClinicalTrials.gov ID is recorded as NCT01016717^[12].
• Clopidogrel Proton-Pump Inhibitors Study's maximum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+80'}^[13].
• Clopidogrel Proton-Pump Inhibitors Study's research intervention is recorded as Omeprazole / Sodium Bicarbonate^[14].
• Clopidogrel Proton-Pump Inhibitors Study's clinical trial phase is recorded as phase IV clinical trial^[15].
• Clopidogrel Proton-Pump Inhibitors Study's research site is recorded as Tel Aviv University^[16].
• Clopidogrel Proton-Pump Inhibitors Study's study type is recorded as interventional study^[17].